Clinical Trial Update: A Study of NDI 1150-101 in Patients With Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Nimbus Saturn, Inc. is conducting a Phase 1/2 trial of NDI 1150-101 in patients with solid tumors, including renal cell carcinoma, gastric cancer, gastroesophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer
• Gastroesophageal Junction Adenocarcinoma
• Non-small Cell Lung Cancer
• Renal Cell Carcinoma

Drugs mentioned

• NDI 1150-101

Snippet

Sponsor: Nimbus Saturn, Inc. | Conditions: Solid Tumor, Renal Cell Carcinoma (Kidney Cancer) | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING